Zacks Research Downgrades Air Liquide (OTCMKTS:AIQUY) to Strong Sell

Air Liquide (OTCMKTS:AIQUY) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Monday,Zacks.com reports.

Separately, Kepler Capital Markets upgraded shares of Air Liquide from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Air Liquide Price Performance

OTCMKTS:AIQUY opened at $41.50 on Monday. The stock’s 50-day moving average is $39.42 and its 200-day moving average is $39.00. Air Liquide has a 1-year low of $34.76 and a 1-year high of $43.12. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.90 and a current ratio of 1.14.

Institutional Trading of Air Liquide

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AIQUY. Rhumbline Advisers increased its position in Air Liquide by 0.4% during the 2nd quarter. Rhumbline Advisers now owns 70,948 shares of the basic materials company’s stock valued at $2,931,000 after purchasing an additional 314 shares during the period. GAMMA Investing LLC lifted its position in shares of Air Liquide by 15.3% in the 3rd quarter. GAMMA Investing LLC now owns 7,822 shares of the basic materials company’s stock worth $324,000 after purchasing an additional 1,039 shares during the period. Finally, Salomon & Ludwin LLC boosted its stake in shares of Air Liquide by 1,692.0% in the 3rd quarter. Salomon & Ludwin LLC now owns 1,344 shares of the basic materials company’s stock valued at $54,000 after purchasing an additional 1,269 shares during the last quarter. Institutional investors and hedge funds own 0.04% of the company’s stock.

About Air Liquide

Air Liquide is a Paris‑headquartered multinational that develops, manufactures and supplies industrial and medical gases, related equipment and services. Founded in 1902, the company has grown into a major global supplier of gases such as oxygen, nitrogen, argon, hydrogen and a wide range of specialty gases used across industrial, healthcare and research applications.

Its core activities include on‑site gas production, bulk and packaged gas distribution (cylinders and cryogenic deliveries), installation and maintenance of gas handling and storage equipment, and engineering for large industrial gas projects.